Edmonton, Canada

Diane Jette

This inventor holds 1 USPTO granted patent. Top assignee: Biomira, Inc.. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Diane Jette: Innovator in Antibody Screening

Introduction

Diane Jette is a notable inventor based in Edmonton, Canada. She has made significant contributions to the field of immunology through her innovative work in antibody screening. Her research focuses on identifying antibodies that bind to carbohydrate epitopes, which has important implications for immunodiagnosis and immunotherapy.

Latest Patents

Diane Jette holds a patent for a method of screening for antibodies that bind carbohydrate epitopes. This patent, which is her only one, describes a process where cells producing these antibodies are identified by screening with mucinous body fluids. The method allows for the detection of fine differences in antibody specificity, which can be crucial for various immunological applications. The antibodies identified through this method have shown to be relatively insensitive to pH, making them particularly valuable in immunological methods where pH is a consideration.

Career Highlights

Diane Jette has worked at Biomira, Inc., where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to advancements in the understanding and application of antibodies in medical science.

Collaborations

Some of her notable coworkers include Mavanur Suresh and Anneke Van Heel, who have collaborated with her on various projects related to antibody research.

Conclusion

Diane Jette's contributions to the field of immunology through her patent and work at Biomira, Inc. highlight her role as an innovator in antibody screening. Her research continues to impact the development of immunological methods and therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…